IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Jones Hill Capital LP

Q1 2026 Holdings

Filed 2026-05-14 | 26 holdings | $466.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$71.7M1,268,39015.4%
Vertex Pharmaceuticals Inc(VRTX)COM92532F100$48.5M108,60310.4%
Vaxcyte Inc(PCVX)COM92243G108$37.5M644,8318.0%
Nuvalent Inc(NUVL)COM670703107$30.8M300,8306.6%
Capricor Therapeutics Inc(CAPR)COM NEW14070B309$27.6M909,2075.9%
Terns Pharmaceuticals Inc(TERN)COM880881107$27.5M521,2375.9%
Bicara Therapeutics Inc(BCAX)COM055477103$25.1M1,260,1365.4%
ANI Pharmaceuticals Inc(ANIP)COM00182C103$24.5M318,5915.3%
Ultragenyx Pharmaceutical in(RARE)COM90400D108$24.4M1,165,5575.2%
Enliven Therapeutics Inc(ELVN)COM29337E102$23.2M593,0405.0%
Amylyx Pharmaceuticals Inc(AMLX)COM03237H101$22.2M1,598,7944.8%
Argenx SE(ARGX)SPONSORED ADR04016X101$19.0M25,9954.1%
Fulcrum Therapeutics Inc(FULC)COM359616109$13.6M1,771,9262.9%
VIR Biotechnology Inc(VIR)COM92764N102$10.7M1,198,2132.3%
Nuvation BIO Inc(NUVB)COM CL A67080N101$10.2M2,383,0312.2%
Oruka Therapeutics Inc(ORKA)COM687604108$6.9M140,8431.5%
Contineum Therapeutics Inc(CTNM)CL A21217B100$6.7M513,0531.4%
Veradermics Inc(MANE)COMMON STOCK922967104$6.4M100,8431.4%
Tonix Pharmaceuticals Hldg C(TNXP)COM NEW890260839$6.2M452,1161.3%
Structure Therapeutics Inc(GPCR)SPONSORED ADS86366E106$4.8M100,5931.0%
Entrada Therapeutics Inc(TRDA)COM29384C108$4.7M374,0101.0%
Pharvaris N V(PHVS)COMN69605108$4.7M167,0141.0%
Trevi Therapeutics Inc(TRVI)COM89532M101$4.4M370,1750.9%
Relmada Therapeutics Inc(RLMD)COM75955J402$2.4M342,7520.5%
Silence Therapeutics PLC(SLN)ADS82686Q101$1.6M301,6040.3%
Arrivent Biopharma Inc(AVBP)COM04272N102$1.1M45,8090.2%